Global Statistics

All countries
136,016,303
Confirmed
Updated on April 10, 2021 11:15 pm
All countries
109,346,544
Recovered
Updated on April 10, 2021 11:15 pm
All countries
2,939,231
Deaths
Updated on April 10, 2021 11:15 pm
Saturday, April 10, 2021

Global Statistics

All countries
136,016,303
Confirmed
Updated on April 10, 2021 11:15 pm
All countries
109,346,544
Recovered
Updated on April 10, 2021 11:15 pm
All countries
2,939,231
Deaths
Updated on April 10, 2021 11:15 pm
Molderizer and Safe Shield

Research examines market design to accelerate COVID-19 vaccine supply

Covid-19 and Vaccine News: Live Updates

Here’s what you need to know:A nurse administering a coronavirus vaccine to a frontline worker at East West Rescue, a medical center, in...

Medical System Still In Dire Need Of Supplies To Battle Coronavirus | TODAY

Private companies are stepping up to fill the desperate need of equipment and supplies for health-care workers to battle the coronavirus pandemic, but critics...

WTO debates suspending coronavirus vaccine patents

A number of developing nations are calling on the World Trade Organization to suspend patents for coronavirus vaccines so that they can be produced...

Michigan governor pushes voluntary efforts to curb coronavirus flare

Michigan Gov. Gretchen Whitmer is declining to order state-wide lockdowns in response to her state experiencing the most severe Covid-19 outbreak...

Fishers Island C-19 Vaccine POD Info – FishersIsland.net

Continued thanks to all those individuals who worked to have the POD at Fishers Island become a reality and to all who participated. Having...


Each month, COVID-19 kills hundreds of thousands of people, reduces global gross domestic product (GDP) by hundreds of billions of dollars, and generates large, accumulating losses to human capital by harming education and health. Achieving widespread immunization 1 month faster would thus save many lives and mitigate short- and long-run economic harm. Although the value of vaccines may seem obvious, government action and investment in vaccines have not been commensurate with the enormous scale of benefits, with many countries not likely to achieve widespread immunization until the end of 2022.

In this paper, recently published in Science, Stanford Graduate School of Business Professor of Economics (by courtesy) Susan Athey and 15 co-authors argue that investing in a greater capacity for vaccine development now will pay enormous dividends in both lives saved and economic harm averted.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Covid-19 and Vaccine News: Live Updates

Here’s what you need to know:A nurse administering a coronavirus vaccine to a frontline worker at East West Rescue, a medical center, in...

Medical System Still In Dire Need Of Supplies To Battle Coronavirus | TODAY

Private companies are stepping up to fill the desperate need of equipment and supplies for health-care workers to battle the coronavirus pandemic, but critics...

WTO debates suspending coronavirus vaccine patents

A number of developing nations are calling on the World Trade Organization to suspend patents for coronavirus vaccines so that they can be produced...

Related Articles

Covid-19 and Vaccine News: Live Updates

Here’s what you need to know:A nurse administering a coronavirus vaccine to a frontline worker at East West Rescue, a medical center, in...

Medical System Still In Dire Need Of Supplies To Battle Coronavirus | TODAY

Private companies are stepping up to fill the desperate need of equipment and supplies for health-care workers to battle the coronavirus pandemic, but critics...

WTO debates suspending coronavirus vaccine patents

A number of developing nations are calling on the World Trade Organization to suspend patents for coronavirus vaccines so that they can be produced...